vrc-chkvlp059-00-vp
Vaccineexperimental
Clinical trial activity
2 trials · 9 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Dec 1, 2011 (NCT01489358)
Timeline
Indications
Mechanism of action
- Chikungunya virusImmunity, active
Chikungunya virus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- vrc-chkvlp059-00-vp
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02562482 | Phase 2 | Oct 1, 2015 | FHI 360, GHESKIO, Haiti, Leidos, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Puerto Rico Clinical and Translational Reserach Consortium, The EMMES Corporation, University Hospital Pointe-a-Pitre, Guadeloupe, University of the French West Indies and French Guiana |
| NCT01489358 | Phase 1 | Dec 1, 2011 | National Institute of Allergy and Infectious Diseases (NIAID) |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (9)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| National Institute of Allergy and Infectious Diseases (NIAID) | Government | 2 | 2 | 2 | 2011 |
| FHI 360 | Academic/Hospital | 1 | 0 | 1 | 2015 |
| GHESKIO, Haiti | Academic/Hospital | 1 | 0 | 1 | 2015 |
| Leidos | For profit | 1 | 0 | 1 | 2015 |
| National Institutes of Health (NIH) | Government | 1 | 0 | 1 | 2015 |
| Puerto Rico Clinical and Translational Reserach Consortium | Academic/Hospital | 1 | 0 | 1 | 2015 |
| The EMMES Corporation | For profit | 1 | 0 | 1 | 2015 |
| University Hospital Pointe-a-Pitre, Guadeloupe | Academic/Hospital | 1 | 0 | 1 | 2015 |
| University of the French West Indies and French Guiana | Academic/Hospital | 1 | 0 | 1 | 2015 |
9 organizations
Page 1 / 1